Akers Biosciences, Inc.
15 November 2004
Akers Biosciences, Inc. (the 'Company')
Akers Biosciences, Inc. today announces that on 11 November 2004 it approved the
issue of 27,300 shares of common stock, no par value ('Common Shares') to Daniel
Seckinger, non-executive board member, which represents 0.06% of the total
issued share capital. The shares were issued at $1.19 (64 pence) per share,
which was the closing mid-market price on 11 November 2004. The total
consideration for this purchase was $32,487 (£17,466).
Following this announcement, Daniel Seckinger is the owner of 368,189 common
shares or 0.79% of the issued capital.
For the purposes of this announcement, the exchange rate used is £1: $1.86.
Application has been made to the London Stock Exchange for the 27,300 Common
Shares to be admitted to trading, such admission expected to take place on 19
November 2004. Following this announcement, the Company has 46,790,836 shares of
common stock in issue.
Paul Freedman - 00 1 856 848 2116
This information is provided by RNS
The company news service from the London Stock Exchange